Edgewell Personal Care (EPC) FY2025 results: revenue $2.2 billion, down 1.3% on the year
Edgewell Personal Care Co. (EPC) reported revenue of $2.2 billion for fiscal 2025, the year ended 30 September 2025, down 1.3% on the year before. Net income was $25 million, down 74.2%, and diluted earnings per share $0.53. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2025.
Revenue
$2.2 billion
-1.3% on the year
FY2018FY2025
Operating margin
4.3%
8.8% a year earlier
FY2018FY2025
Net income
$25 million
-74.2% on the year
FY2018FY2025
Diluted EPS
$0.53
-73.1% on the year
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 14 new.
Fourth-quarter sales rose 3.8%: Net sales were $537.2 million, up $19.6 million. Organic sales rose $12.9 million, or 2.5%, and currency added $6.7 million, or 1.3%.
Quarter operating loss on impairment: Operating loss of $36.3 million included a non-cash goodwill impairment of $51.1 million on the Feminine Care reporting unit, tied to the planned sale.
Quarter EPS shows GAAP loss: GAAP diluted EPS was a loss of $0.66, against $0.17 a year earlier. Adjusted EPS was $0.68, against $0.72, with a $0.19 currency impact.
Sun and Skin Care profit down 61%: Sun and Skin Care net sales rose 11.5% on volume growth, but organic segment profit fell 61.4% on lower gross margin and higher marketing and SG&A.
Gross margin fell on mix and tariffs: Adjusted gross margin fell 330 basis points to 39.3%. Mix and other, tariffs, inflation and promotions outweighed productivity and absorption gains.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
118
-231
-216
Capital expenditure
77.0
56.5
49.5
+36.3%
Free cash flow
41.4
-288
-266
Free cash flow margin
1.9%
-12.8%
-11.8%
Cash from investing
-72.9
-62.4
-50.5
Cash from financing
-30.0
-179
-146
Depreciation and amortisation
88.8
88.0
91.4
+0.9%
Share-based compensation
24.5
26.5
27.5
-7.5%
Buybacks
90.2
58.5
75.2
+54.2%
Dividends paid
29.3
30.7
31.5
-4.6%
Diluted shares, weighted
48m
50m
52m
-5.0%
Shares outstanding at period end
46m
49m
50m
-5.0%
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
1,553
1,584
1,540
-2.0%
Debt
1,413
1,300
1,380
+8.7%
Operating lease liabilities
57.1
69.8
53.9
-18.2%
Other liabilities
733
778
766
-5.7%
Total liabilities and equity
3,756
3,731
3,741
+0.7%
Fixed assets
369
349
338
+5.8%
Goodwill
1,291
1,339
1,331
-3.5%
Intangible assets
921
948
974
-2.9%
Cash and equivalents
226
209
216
+7.9%
Receivables
138
109
106
+26.0%
Inventory
485
477
492
+1.6%
Other assets
326
299
283
+9.2%
Total assets
3,756
3,731
3,741
+0.7%
10-K for the year ended 30 September 2025, filed 18 November 2025: the filing.